经过评估,专家小组得出结论,在建议的使用条件下低聚异麦芽糖作为新型食品是安全的。部分原文报道如下:
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the extension of use of isomalto-oligosaccharide (IMO) as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF co
nsists of glucose oligomers with degrees of polymerisation of 3C9, along with various amounts of mono- and disaccharides. The NF comes in both syrup and powder form. The applicant intends to extend the current uses of the NF as an ingredient in several foods, and use the NF in food supplements aimed at the general population older than 10 years of age. The information provided on the manufacturing process, composition and specifications of the NF is sufficient and does not raise safety concerns. Along with literature data, the applicant carried out a tolerability study in adult volunteers with the NF at doses up to 120?g/day. The Panel co
ncludes that this study provides reassurance that the NF is tolerable at doses of 120 g/day. Co
nservative intake estimates resulting from the use of the NF as an ingredient according to the currently authorised uses and new proposed uses result in a highest intake estimate in adolescents of 112 g/day at the 95th percentile, and reach 142 g/day in adolescents when the use as a food supplement is included. The Panel notes this amount is higher than the dose of 120 g/day for which tolerability has been demonstrated. However, co
nsidering the source, compositio
nal characterisation, production process and nature of the NF, as well as the available nutritio
nal and toxicological data on the NF, the Panel co
nsiders that the NF does not present safety co
ncerns under the proposed co
nditions of use.
本文由食品伙伴网食品资讯中心编辑,供网友参考,有任何疑问,请联系news@www.sqrdapp.com、/span>